RB1 and breast cancer: In breast cancer alone, up to 50% of patients with Rbness in the absence of RB1 genomic alterations harbored amplifications in PIK3CA, RB (CCND1 and CCNE1), and ER signaling modules (ESR1, FOXA1, and GATA3).